April 26, 2010
HUNDESTED, DenmarkBifodan, developer and manufacturer of probiotic solutions, introduced a patented enteric coatingProTarget, designed for probiotic capsules. According to the company, an independent study and recent in-vitro trials demonstrated ProTarget complies with the U.S. pharmacopoeia for gastro resistant capsules. ProTarget provides significant protection of the probiotics from simulated gastric acid and assures delivery end release of high numbers of viable probiotics at an intestinal pH level.
You May Also Like
The rise of ashwagandha: A case study in a growing and evolving category – articleNov 28, 2023
Ashwagandha: Roots for wellness, leaves for soil – articleNov 28, 2023
Creatine, whey protein, beta-alanine among picks in NFL-style draft at SupplySide WestDec 01, 2023
Unleash the power of ‘combos’ supplements to meet consumer demand – infographicNov 22, 2023